Christopher M. Lindblom
Geen lopende functies
Profiel
Christopher M.
Lindblom worked as Secretary, Treasurer, SVP-Finance & Administration at DNIB Unwind, Inc. from 2014 to 2016.
Prior to that, he was Chief Accounting Officer & Vice President-Finance at Infinity Pharmaceuticals, Inc. from 2006 to 2013.
He also worked as Treasurer & Vice President-Finance at Infinity Pharmaceuticals, Inc. in 2016 and at OvaScience, Inc. in 2014.
Lindblom holds an MBA from Boston College and an undergraduate degree from Syracuse University.
Eerdere bekende functies van Christopher M. Lindblom
| Bedrijven | Functie | Einde |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25-07-2016 |
| DNIB UNWIND INC | Financieel Directeur/CFO | 21-03-2016 |
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 12-04-2013 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Financieel Directeur/CFO | 07-06-2013 |
Opleiding van Christopher M. Lindblom
| Boston College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
